Growth Metrics

Guardant Health (GH) Gains from Investment Securities (2017 - 2025)

Guardant Health (GH) has disclosed Gains from Investment Securities for 9 consecutive years, with $16.0 million as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities fell 6.59% to $16.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $41.2 million through Dec 2025, up 162.89% year-over-year, with the annual reading at $41.2 million for FY2025, 162.89% up from the prior year.
  • Gains from Investment Securities hit $16.0 million in Q4 2025 for Guardant Health, down from $24.9 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $171.3 million in Q4 2021 to a low of -$170.8 million in Q3 2021.
  • Historically, Gains from Investment Securities has averaged $11.5 million across 5 years, with a median of $1.2 million in 2022.
  • Biggest YoY gain for Gains from Investment Securities was 512389.47% in 2021; the steepest drop was 7765.26% in 2021.
  • Year by year, Gains from Investment Securities stood at $171.3 million in 2021, then plummeted by 101.43% to -$2.4 million in 2022, then skyrocketed by 52.21% to -$1.2 million in 2023, then soared by 1569.03% to $17.2 million in 2024, then decreased by 6.59% to $16.0 million in 2025.
  • Business Quant data shows Gains from Investment Securities for GH at $16.0 million in Q4 2025, $24.9 million in Q3 2025, and $1.2 million in Q2 2025.